Erevna Innovations Inc. has launched recruitment for an advanced clinical trial focusing on microneedling combined with the topical application of VAMP™ ADVANCED Topical Multivitamin Serum. This innovative approach aims to address aesthetic skin health concerns. Professionals in regulatory, clinical, and quality domains may find this development both significant and instructive.
What is this clinical trial about?
The study investigates the combined use of a microneedling device and the VAMP™ ADVANCED Topical Multivitamin Serum in improving skin health. Microneedling is a minimally invasive procedure designed to promote skin rejuvenation and address various aesthetic concerns. This trial’s goal is to evaluate both the performance and safety of the product when applied topically in conjunction with microneedling.
Participants in the trial will undergo microneedling treatments paired with the serum, which contains a proprietary blend of multivitamins. Erevna Innovations Inc., the sponsor of the trial, emphasizes the intention to expand evidence supporting innovative technologies in aesthetic procedures.
How does microneedling with VAMP™ ADVANCED work?
Microneedling involves the use of a device equipped with fine needles that create controlled micro-injuries to the skin. This promotes collagen production and enhances skin repair processes over time. The addition of VAMP™ ADVANCED Topical Multivitamin Serum aims to augment these benefits by delivering targeted vitamins directly into the dermis during the procedure.
The serum leverages a specialized formulation designed to optimize skin absorption and regeneration. While initial results from earlier studies have demonstrated promising outcomes, this trial seeks to establish more robust clinical data to confirm safety and efficacy.
Who is impacted by this trial?
The trial primarily targets individuals with aesthetic skin concerns who could benefit from enhanced skin health. Additionally, clinicians specializing in dermatology or aesthetic medicine may find the results of this study pertinent for shaping treatment offerings.
Moreover, regulatory professionals will be closely observing the study to understand how emerging technologies like VAMP™ ADVANCED align with current medical device regulations and clinical standards.
FAQ
1. What is the intended purpose of the VAMP™ ADVANCED serum?
The serum is designed to improve skin health in aesthetic applications, particularly when used in combination with microneedling procedures.
2. Is this trial currently recruiting participants?
Yes, recruitment is active as of October 2025.
3. Who is sponsoring the study?
Erevna Innovations Inc. is the sponsor of the clinical trial.
4. Is the trial registered?
Yes, the trial is registered on ClinicalTrials.gov under the identifier NCT07210190.
Conclusion
The clinical trial for microneedling with VAMP™ ADVANCED Serum represents an important step in advancing aesthetic skin health technologies. Both clinicians and regulatory teams should monitor its progress for insights into innovative treatment modalities and compliance pathways. This development underscores the proactive steps in aligning advancements with evidence-based practices.
Disclaimer
This article is intended for informational purposes only and does not constitute professional or legal advice. Regulatory compliance and clinical decisions should always be informed by consultation with qualified experts.
Full trial details
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07210190?term=medical+device